Clinical Trial Supply: Minimising Wastage in Time and Money




We respect your privacy, by clicking "Download Your Copy" you will receive our e-newsletter, including information on Podcasts, Webinars, event discounts, online learning opportunities and agree to our User Agreement. You have the right to object . In addition, you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest subject to their privacy policy. For further information on how we process and monitor your personal data click here. You can unsubscribe at any time.

The operation of clinical trials are integral to the progression of the pharmaceutical industry. These trials can be orchestrated on a global scale, producing and distributing the drug in question to participants over several years.
Therefore, the supply of these trials represents one of the biggest challenges to be navigated. Undoubtedly, the efficient management of clinical trial supply entails regulating two dominant variables: time and money.
It is estimated that in total, it takes more than 15 years to develop, test and license a new drug and sometimes billions to fund the process. Badly budgeted or scheduled clinical trials can have the potential to severely hinder the progress made.
[inlinead]
As a result of these considerations being of prime importance to the R&D industry, Pharma IQ discussed the concept with a clinical trial supply expert - Dr. Andrea Zobel Global Senior Portfolio Director Clinical Logistics at Parexel.
Have Your Say
Rate this feature and give us your feedback in the comments section below

RECOMMENDED